American Society for Clinical Pharmacology & Therapeutics 2023 (ASCPT)
Mar. 22nd - 24th, 2023 | Atlanta, GA
EXPERIENCES OF CSF COLLECTION BY SERIAL SAMPLING OR LUMBAR PUNCTURE IN CLINICAL PHARMACOLOGY RESEARCH
Peter Dogterom, PhD presented Experiences of CSF collection by serial sampling or lumbar puncture in clinical pharmacology research at ASCPT 2023 in March 2023.
SfN Meeting 2022
Nov. 12th - 16th, 2022 | San Diego, CA, USA
PHENOTYPIC CHARACTERIZATION OF hA53Ttg MICE AS PARKINSON’S DISEASE MODEL
Tina Loeffler, Marlene Mikusch, Richard Scheytt, Joerg Neddens, Roland Rabl, Magdalena Daurer, Livia Breznik, Sara Peinkiher, Stefanie Flunkert, Spyridon Sideromenos, Manuela Prokesch
NEUROINFLAMMATION IN THE EAE MODEL OF MULTIPLE SCLEROSIS
Joerg Neddens, Magdalena Daurer, Livia Breznik, Roland Rabl, Tina Loeffler, Sara Peinkiher, Stefanie Flunkert, Manuela Prokesch
FENS Forum 2022
Jul. 9th - 13th, 2022 | Paris, France
Fmr1-KO MICE, A SUITABLE TOOL TO STUDY CORE AND SECONDARY SYMPTOMS OF AUTISM SPECTRUM DISORDERS
Shirin Sharghi1,2, Stefanie Flunkert1, Magdalena Daurer1, Spyridon Sideromenos1, Boris Philippe Chagnaud2, Marcello Leopoldo3, Enza Lacivita3, Birgit Hutter-Paier1, and Manuela Prokesch1
REID Bioanalytical Forum 2022
Jun. 14th - 16th, 2022 | Cambridge, UK
Metallo Protein Quantitation by (LC-)ICP-MS
Eric van der Horst
Eric van der Horst presented Metallo Protein Quantitation by (LC-)ICP-MS on Tuesday, June 14, 2022
The Neuro4D Conference 2022
May. 16th - 17th, 2022 | Mainz, Germany
INCREASED RESPONSE OF 5XFAD MOUSE PRIMARY ADULT MICROGLIA TO DIFFERENT PRO-INFLAMMATORY STIMULI
Roland Rabl, Irene Schilcher, Tina Loeffler, Birgit Hutter-Paier, Manuela Prokesch
INJECTION OF PATIENT-DERIVED TAU SEEDS IN THE HIPPOCAMPUS OF HTAU MICE RESULTS IN TAU PHOSPHORYLATION AT SEVERAL RESIDUES
Roland Rabl, Irene Schilcher, Tina Loeffler, Martina Scharf, Magdalena Daurer, Joerg Neddens, Birgit Hutter-Paier, Manuela Prokesch
A NEW HUMAN Α-SYNUCLEIN A53T MOUSE MODEL EXHIBITING MULTIPLE PD-LIKE PHENOTYPES
Manuela Prokesch
Manuela Prokesch, PhD will be giving a presentation on Monday, May 16, 2022 at 14:00 (CEST)
AD/PD™ 2022
Mar. 15th - 20th, 2022 | Barcelona, Spain & Virtual Event
BEHAVIORAL CHARACTERIZATION OF HOMOZYGOUS 6NEO POMPE MICE
Spyridon Sideromenos, Agnes Molnar-Kasza, Livia Breznik, Roland Rabl, Stefanie Flunkert, Manuela Prokesch, Birgit Hutter-Paier
HUMAN ALZHEIMER’S DISEASE TAU SEEDS INCREASE TAU SEEDING AND UPTAKE IN DIFFERENT IN VITRO MODELS
Irene Schilcher, Tina Loeffler, Manuela Prokesch, Birgit Hutter-Paier
INCREASED RESPONSE OF PRIMARY ADULT MICROGLIA FROM 5xFAD MICE TO PRO-INFLAMMATORY STIMULI
Irene Schilcher, Tina Loeffler, Manuela Prokesch, Birgit Hutter-Paier
EDARAVONE REDUCES TDP-43 LEVEL BUT NOT STRESS GRANULE FORMATION IN SODIUM ARSENITE TREATED TDP-43 OVEREXPRESSING CELLS
Irene Schilcher, Tina Loeffler, Manuela Prokesch, Birgit Hutter-Paier
NEUROPROTECTIVE EFFECTS OF ASTAXANTHIN IN PRECLINICAL MODELS OF ALZHEIMER’S DISEASE
Babalola Joshua Adekunle1,2, Löffler Tina2, Schilcher Irene2, Manuela Prokesch2, Gerald Hoefler1 and Birgit Hutter-Paier2
Oral Presentation: DISTRIBUTION OF TAU PHOSPHORYLATION AT SEVERAL RESIDUES AFTER INJECTION OF PATIENT-DERIVED SEEDS IN A TAU MOUSE MODEL
Irene Schilcher, Tina Löffler, Martina Scharf, Magdalena Daurer, Joerg Neddens, Manuela Prokesch, Birgit Hutter-Paier
Oral Presentation: BEHAVIORAL CHARACTERIZATION OF THE hA53Ttg OF PARKINSON’S DISEASE
Roland Rabl, Magdalena Daurer, Livia Breznik, Helena Aspernig, Stefanie Flunkert, Birgit Hutter-Paier, Manuela Prokesch
WORLDSymposium™ 2022
Feb. 7th - 11th, 2022 | San Diego, CA & Virtual Event
CHARACTERIZATION OF IN VIVO AND IN VITRO DRUG SCREENING MODELS FOR GAUCHER DISEASE BASED ON GBA-D409V-KI MICE
Tina Loeffler, Breznik Livia, Ewald Auer, Irene Schilcher, Birgit Hutter-Paier, Manuela Prokesch
Tina Loeffler, PhD will present the abstract during a moderated poster session on Thursday, February 10, 2022 from 3:00-5:00 PM (PST)
BEHAVIORAL CHARACTERIZATION OF HOMOZYGOUS 6NEO MICE AS MODEL OF POMPE DISEASE
Livia Breznik, Spyridon Sideromenos, Agnes Molnar-Kasza, Roland Rabl, Stefanie Flunkert, Manuela Prokesch, Birgit Hutter-Paier
Livia Breznik, MSc will present the abstract during a moderated poster session on Thursday, February 10, 2022 from 3:00-5:00 PM (PST)
EBF Open Symposium 2021
Nov. 24th - 26th, 2021 | Barcelona, Spain
THE DEVELOPMENT OF A HYBRIDIZATION ECLIA ASSAY FOR THE DETERMINATION OF THE PAYLOAD OF A OLIGONUCLEOTIDE-ANTIBODY CONJUGATE
Niels Nijstad, PhD
Niels Nijstad, PhD will be making a presentation on Day 1 – Wednesday 24th Nov. 2021 14:40 - 15:00.
17th ANA Meeting 2021 (Austrian Neuroscience Association) 2021
Sep. 28th - 30th, 2021 | Salzburg, Austria
BEHAVIOURAL CHARACTERIZATION OF THE FMR1 KNOCK-OUT MOUSE MODEL OF AUTISM SPECTRUM DISORDER (ASD)
Shirin Sharghi1,2, Magdalena Daurer1, Stefanie Flunkert1, Boris Philippe Chagnaud2, Marcello Leopoldo3, Enza Lacivita3 and Birgit Hutter-Paier1
Alzheimer’s Association International Conference® 2021
Jul. 26th - 30th, 2021 | Denver, USA and Virtual Event
ASTAXANTHIN ENHANCES LRP1-MODULATED INSULIN SENSITIVITY AND AMYLOID BETA CLEARANCE IN AN IN VITRO BLOOD-BRAIN BARRIER MODEL
Joshua Adekunle Babalola1,2,3, Magdalena Lang2, Meekha George2, Anika Stracke2, Jelena Tadic4, Frank Madeo4, Achim Lass4, Gerd Leitinger5, Birgit Hutter-Paier3, Gerald Hoefler1 and Ute Panzenboeck2
ENCODS 2021
Jun. 4th - 6th, 2021 | Virtual Event
BTBR T+ Itpr3tf/J MICE, A SUITABLE ANIMAL MODEL TO STUDY ANXIETY AND REPETITIVE BEHAVIORS IN AUTISM SPECTRUM DISORDER
Shirin Sharghi1,2, Magdalena Daurer1, Stefanie Flunkert1, Boris Philippe Chagnaud2, Marcello Leopoldo3, Enza Lacivita3 and Birgit Hutter-Paier1
AD/PD™ 2021 Conference
Mar. 9th - 14th, 2021 | Virtual Event
A53T-MUTATED HUMAN Α-SYNUCLEIN IS INVOLVED IN BLOOD GLUCOSE REGULATION OF WESTERN TYPE DIET-FED PARKINSON’S DISEASE MICE
Magdalena Daurer1,2, Roland Rabl1, Heinrich Roemer2, Birgit Hutter-Paier1
IN VITRO AND IN VIVO MODELING OF MUTATED A53T ALPHA-SYNUCLEIN PATHOLOGY
Tina Loeffler, Roland Rabl, Irene Schilcher, Magdalena Daurer, Stefanie Flunkert, Birgit Hutter-Paier
REPURPOSING OF THE ANTI-ASTHMATIC DRUG MONTELUKAST FOR THE TREATMENT OF PARKINSON’S DISEASE
Katharina Strempfl1,2,3, Michael S. Unger2,3, Ludwig Aigner2,3, Jörg Neddens1, Stefanie Flunkert1, Birgit Hutter-Paier1
COMPARISON OF TWO DIFFERENT IN VITRO MODELS OF NEUROINFLAMMATION: CYTOKINE RELEASE AND INFLAMMASOME ACTIVATION IN ORGANOTYPIC SLICES AND BV2 CELLS
Irene Schilcher, Tina Loeffler, Stefanie Flunkert, Birgit Hutter-Paier
TREATMENT OF APPSL TRANSGENIC MICE WITH AN ALDH2 ACTIVATOR AS A PROMISING TREATMENT OPTION FOR ALZHEIMER’S DISEASE
Barbara Hinteregger1,2, Stefanie Flunkert1, Tobias Madl2, Joerg Neddens1, Wenjin Yang3 and Birgit Hutter-Paier1
WORLDSymposium™ 2021 Virtual Annual Meeting
Feb. 8th - 12th, 2021 | Virtual Event
CHARACTERIZATION OF 4L/PS-NA MICE FOR CYTOKINE ACTIVITY AND NEURODEGENERATION
Tina Loeffler, Ewald Auer, Irene Schilcher, Birgit Hutter-Paier
Tina Loeffler, Ph. D. will be taking part in a Live Q&A on Thursday, February 11 from 2:30-3:30pm EST
EVALUATION OF CD45 POSITIVE CELLS IN THE BRAIN AND LIVER OF NPC1-/- MICE
Magdalena Daurer, Ewald Auer, Joerg Neddens, Birgit Hutter-Paier
Magdalena Dauerer, Ph.D. will be taking part in a Live Q&A on Thursday, February 11 from 2:30-3:30pm EST
EBF Open 2020
Nov. 17th - 20th, 2020 | Virtual Event
DEVELOPMENT AND VALIDATION OF A TRASTUZUMAB/PERTUZUMAB HYBRID LC-MS ASSAY FOR CLINICAL DEVELOPMENT
Fabrizia Fusetti, Ph.D.
Fabrizia Fusetti, Ph.D. will be making a presentation on Day 2, 18 November 2020 14:30-14:50.
STRATEGIES FOR THE PREVENTION OF NON-SPECIFIC BINDING IN THE QUANTITATIVE DETERMINATION OF DRUGS IN CEREBROSPINAL FLUID
Martijn Hilhorst, Robbert Edens, Bert Ottjes, Benjamin Steenge and Ben van Baar
DEVELOPMENT OF A HYBRID METHOD FOR SIMULTANEOUS QUANTIFICATION OF TWO NEAR IDENTICAL PROTEINS IN PLASMA
Chris Williams, Thomas Fokkinga, Francesco Bonardi, Fabrizia Fusetti and Martijn Hilhorst
TIDES Europe 2020
Nov. 11th - 13th, 2020 | Virtual Event
BIOANALYTICAL MONITORING OF GENE THERAPY TRIALS: METHODOLOGIES FOR PK PROFILING OF OLIGONUCLEOTIDES
Fabrizia Fusetti1, Zamas Lam2, Monique Putman1, Susan Zondlo2, Brad Yuska2, Lakshmi Ramanathan2, Tim Snow2
AAIC 2020
Jul. 27th - 31st, 2020 | Virtual Event
NEUROFILAMNENT-LIGHT CHAIN IN MURINE MODELS OF NEURODEGENERATIVE AND RARE DISEASES
Irene Schilcher, Tina Loeffler, Stefanie Flunkert, Birgit Hutter-Paier
INFLAMMASOME ACTIVATION AND REDUCED sTREM2 RELEASE IN LPS STIMULATED ORGANOTYPIC BRAIN SLICES
Irene Schilcher, Tina Loeffler, Stefanie Flunkert, Birgit Hutter-Paier
CORRELATION OF Aβ-pE(3) AND ptau IN HUMAN AND MOUSE BRAIN
Magdalena Temmel1, Joerg Neddens1, Stefanie Flunkert1, Lauren Walker2, Johannes Attems2, Birgit Hutter-Paier1
2Translational and Clinical Research Institute and Newcastle University Institute for Ageing, Campus for Ageing and Vitality, Newcastle upon Tyne, NE4 5PL, UK
WORLDSymposium™ 2020
Feb. 10th - 13th, 2020 | Orlando, FL
Neuroinflammation in Mouse Models of Two Different Lysosomal Diseases
Vera Niederkofler, Ewald Auer, Victoria Schiffer, Magdalena Temmel, Joerg Neddens, Birgit Hutter-Paier
Delaware Valley Drug Metabolism Discussion Group (DVDMDG) 2020
Jan. 21st - 21st, 2020 | Langhorne, PA
APPLICATION OF LC-HRMS IN PHARMACOKINETICS AND METABOLISM OF OLIGONUCLEOTIDES
Helen Shen, Ph.D.
Poster Time: Tuesday, Jan. 21st at 1:00-1:35 p.m.
Helen Shen, Ph.D., will be giving a presentation on Tuesday, January 21st at 1:00-1:35 p.m. at the Sheraton Bucks County Langhorne about the topic of the poster.
EBF Open 2019
Nov. 20th - 22nd, 2019 | Barcelona, Spain
BIOANALYTICAL MONITORING OF GENE THERAPY TRIALS: METHODOLOGIES FOR PK-PD ASSESSMENT AND PATIENT ELIGIBILITY
Fabrizia Fusetti
Fabrizia Fusetti will be making a presentation during the plenary session in the 02 Auditorium (Innovate) on Friday, November 22nd at 12:10 pm.
DETERMINATION OF MOXIFLOXACIN IN HUMAN PLASMA AND FECES BY LC-MS/MS
Martijn Hilhorst1, Violaine Augustin2, and Robbert Edens1
2Da Volterra
AASLD: The Liver Meeting 2019
Nov. 8th - 12th, 2019 | Boston, Massachusetts
A STUDY TO DETERMINE THE POTENTIAL EFFECTS OF DISSOLUTION RATE AND FOOD ON THE PHARMACOKINETICS OF TRIENTINE 2HCL FOLLOWING SINGLE ORAL ADMINISTRATIONS IN HEALTHY SUBJECTS
Peter Dogterom1, Mireille Gerrits2, Khalid Abd-Elaziz1, Daphne van Scheppingen3, Carlot Kruse3
2In2Clinic, Wageningen, The Netherlands
3Univar B.V., Rotterdam, The Netherlands
AAPS 2019
Nov. 3rd - 6th, 2019 | San Antonio, TX
A DRUG-DRUG INTERACTION STUDY TO STUDY THE EFFECTS OF MULTIPLE DOSES OF THE CYP3A4 MODULATORS ITRACRONAZOLE AND RIFAMPIN ON THE SINGLE DOSE PHARMACOKINETICS OF VATIQUINONE
ChauHwei Fu, Peter Dogterom, Donald Burkindine, Thomas Chou, Christie Elliott, Martin Thoolen
A Drug-Drug Interaction Study to Study the Effects of Multiple Doses of the CYP3A4 Modulators Itraconazole and Rifampin on the Single Dose Pharmacokinetics of Vatiquinone
SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF ACT017, AN ANTI-PLATELET GPVI (GLYCOPROTEIN VI) FAB IN HEALTHY VOLUNTEERS
Peter Dogterom, Christine Voors-Pette, Thomas Chou, Laurien Jullien, Kristell Lebozec, Martine Jandrot-Perrus, Gilles Avenard
INFLUENCE OF RIFAMPIN-MEDIATED OATP1B1/1B3 INHIBITION ON THE PHARMACOKINETICS OF CLAZOSENTAN
Peter Dogterom, Pierre-Eric Juif, Christine Voors-Pette, Mike Ufer, Jasper Dingemanse
A DRUG-DRUG INTERACTION STUDY: THE EFFECTS OF MULTIPLE DOSES OF THE CYP3A4 MODULATORS ITRACONAZOLE AND RIFAMPIN ON THE SINGLE DOSE PHARMACOKINETICS OF VATIQUINONE
Peter Dogterom, ChauHwei Fu, Thomas Chou, Thomas Wade, Christie Elliott, Martin Thoolen
Neuroscience 2019
Oct. 19th - 23rd, 2019 | Chicago, Il
CHARACTERIZATION OF RELEVANT MOUSE MODELS FOR NEW BIOMARKERS
Vera Niederkofler, Tina Loeffler, Stefanie Flunkert, Agnes Kasza, Ewald Auer, Birgit Hutter-Paier
BEHAVIORAL CHARACTERIZATION OF LOW COPY SOD1 G93A TRANSGENIC MICE
Stefanie Flunkert, Roland Rabl, Agnes Kasza, Vera Niederkofler, Ewald Auer, Birgit Hutter-Paier
RELEVANCE OF CHOICE OF BRAIN REGION AND TIME POINT OF ANALYSIS AFTER MPTP LESIONING IN WILDTYPE MICE
Jan Kehr1,3, Victoria Schiffer2, Shimako Yoshitake1, Tina Loeffler2, Vera Niederkofler2, Stefanie Flunkert2, Ewald Auer2, Takashi Yoshitake3, Birgit Hutter-Paier2
CHARACTERIZATION OF 4L/PS-NA MICE FOR DIFFERENT BIOMARKERS TO MODEL GAUCHER DISEASE
Stefanie Flunkert1, Staffan Schmidt2, Tina Loeffler1, Vera Niederkofler1, Joerg Neddens1, Maria Posch1, Ewald Auer1, Jan Kehr2, Birgit Hutter-Paier1
AAIC 2019
Jul. 14th - 18th, 2019 | Los Angeles, CA
P1-112: PROGRESSIVE INCREASE OF ALZHEIMER’S DISEASE PATHOLOGY IN 5XFAD TRANSGENIC MICE
Tina Loeffler, Magdalena Temmel, Jörg Neddens, Irene Schilcher, Birgit Hutter-Paier.
P3-113: UNTANGLING ALZHEIMER´S DISEASE HALLMARKS IN SENSORY SYSTEMS OF RODENT MODELS
Joerg Neddens1, Magdalena Temmel1, Meritxell Aguilo Garcia1,2, Tina Loeffler1, Irati Aiestaran Zelaia1, Vera Niederkofler1, Stefanie Flunkert1, Birgit Hutter-Paier1
2Institute of Molecular Biosciences, University of Graz, Graz, Austria
P4-061: TAU PHOSPHORYLATION PROFILE OF HTAU TRANSGENIC MICE
Joerg Neddens, Tina Loeffler, Magdalena Temmel, Irene Schilcher, David Amschl, Birgit Hutter-Paier
P4-062: IN VITRO MODELS TO STUDY TAU AGGREGATION, PHOSPHORYLATION AND UPTAKE
Tina Loeffler, Irene Schilcher, Stefanie Flunkert, Birgit Hutter-Paier
AD/PD 2019 Conference
Mar. 26th - 31st, 2019 | Lisbon, Portugal
BEHAVIORAL CHARACTERIZATION OF HOMOZYGOUS BACHD RATS
Tina Loeffler1, Stephan Kurat1, Adam Horvath1, Stefanie Flunkert1, Hoa Huu Phuc Nguyen2,3, Robert Wronski1, Birgit Hutter-Paier1
TAU PHOSPHORYLATION PROFILE OF HTAU TRANSGENIC MICE
Joerg Neddens, Tina Loeffler, Magdalena Temmel, Irene Schilcher, David Amschl, Birgit Hutter-Paier
CONSTRUCTION OF A TAU SEED-INJECTION MODEL USING HTAU MICE
Shigeru Akasofu1, Jane Gartlon2, Malcolm Roberts2, Ezat Sajedi3, Rohan de Silva3, Tina Loeffler4, Stephan Duller4, Birgit Hutter-Paier4
INNERVATION OF SKIN SAMPLES OF Α-SYNUCLEIN TRANSGENIC MICE: LINE 61, D-LINE, A53T
Joerg Neddens, Estibaliz Etxebarria, Victoria Krivitsch, Birgit Hutter-Paier
UNTANGLING ALZHEIMER´S DISEASE HALLMARKS IN SENSORY SYSTEMS OF RODENT MODELS
Magdalena Temmel1, Meritxell Aguilo Garcia1,2, Tina Loeffler1, Joerg Neddens1, Irati Aiestaran Zelaia1, Vera Niederkofler1, Stefanie Flunkert1 and Birgit Hutter-Paier1
PROGRESSIVE INCREASE OF ALZHEIMER’S DISEASE PATHOLOGY IN 5XFAD TRANSGENIC MICE
Magdalena Temmel, Tina Loeffler, Joerg Neddens, Irene Schilcher, Birgit Hutter-Paier
ASCPT 2019 Annual Meeting
Mar. 13th - 16th, 2019 | Washington D.C, USA
SAFETY, TOLERABILITY AND PHARMACODYNAMIC RESULTS OF A FIRST IN HUMAN STUDY WITH THE NEW ANTIPLATELET AGENT ACT017 FOR THE TREATMENT OF THE ACUTE PHASE OS ISCHEMIC STROKE
Christine Voors-Pette1, Peter Dogterom1, Laurie Jullien2, Martine Jandrot-Perrus3, and Gilles Avenard2
WORLDSymposium™ (Lysosomal Disease) 2019
Feb. 4th - 8th, 2019 | Orlando, FL
CHARACTERIZATION OF 4L/PS-NA MICE FOR ENZYME ACTIVITY
Vera Niederkofler1, Ewald Auer1, Victoria Schiffer1, Tina Loeffler1, Joerg Neddens1,Staffan Schmidt2, Jan Kehr2, Birgit Hutter-Paier1
BEHAVIORAL AND HISTOLOGICAL HALLMARKS OF A MUCOPOLYSACCHARIDOSIS TYPE IIIA MOUSE MODEL
Vera Niederkofler1, Ewald Auer1, David Amschl1, Joerg Neddens1, Elisabet Ohlin Sjöström2, Susanne Gustavsson2, Birgit Hutter-Paier1
CBE TREATMENT OF Α-SYNUCLEIN OVEREXPRESSING AND WILDTYPE MICE MODELS GAUCHER DISEASE PATHOLOGY
Vera Niederkofler, Ewald Auer, David Amschl, Joerg Neddens, Birgit Hutter-Paier
Neuroscience SFN’s 48th Annual Meeting 2018
Nov. 3rd - 7th, 2018 | San Diego, CA
CONSTRUCTION OF A TAU-SEED INJECTION MODEL USING hTau MICE
Birgit Hutter-Paier1, Shigeru Akasofu2, Jane Gartlon3, Malcolm Roberts3, Ezat Sajedi4, Rohan de Silva4, Tina Löffler1, Stephan Duller1.
2Eisai Co., Ltd., Tsukuba Research Laboratories, Tsukuba, Ibaraki, Japan
3Eisai Ltd, Mosquito Way, Hatfield, UK
4University College London, Reta Lila Weston Institute, London, UK
PATHOLOGICAL HALLMARKS OF A GENETIC AND AN INDUCED GAUCHER DISEASE MOUSE MODEL
Joerg Neddens, Estibaliz Santiago-Mugica, Stefanie Flunkert, Vera Niederkofler, Roland Rabl, David Amschl, Maria Posch, Ewald Auer, Birgit Hutter-Paier.
LEARNING AND MEMORY DEFICITS OF TWO TRANSGENIC ALZHEIMER’S DISEASE MOUSE MODELS IN THE BARNES MAZE TEST
Ewald Auer, Stephan Kurat, Roland Rabl, Iera Hernandez, Stefanie Flunkert, Vera Niederkofler, Birgit Hutter-Paier.
European Huntington’s Disease Network (EHDN) Plenary Meeting 2018
Sep. 14th - 16th, 2018 | Vienna, AT
METABOLIC CHARACTERISTICS OF PRIMARY NEURON CULTURES FROM BACHD RATS COMPARED TO INDUCED LESION MODELS
Stefanie Flunkert1, Tina Loeffler1, Benedikt Fabry1, Hoa Huu Phuc Nguyen2,3, Robert Wronski1, Birgit Hutter-Paier1
2Institute of Medical Genetics and Applied Genomics, Tübingen, Germany
3Department of Human Genetics, Ruhr-University Bochum, Bochum, Germany
BEHAVIORAL CHARACTERIZATION OF HOMOZYGOUS BACHD RATS
Stephan Kurat1, Adam Horvath1, Stefanie Flunkert1, Hoa Huu Phuc Nguyen2,3, Robert Wronski1, Birgit Hutter-Paier1
2Institute of Medical Genetics and Applied Genomics, Tübingen, Germany
3Department of Human Genetics, Ruhr-University Bochum, Bochum, Germany
AAIC 2018 – Alzheimer’s Association International Conference
Jul. 22nd - 26th, 2018 | Chicago, IL
INTEGRATIVE CHARACTERIZATION OF A RODENT ALZHEIMER’S DISEASE MODEL
Barbara Hinteregger1,2, Tobias Madl2, Joerg Neddens1, Robert Wronski1, Birgit Hutter-Paier1
2Medical University Graz, Institute for Molecular Biology and Biochemistry, Graz, Austria
THE BARNES MAZE TEST – A DRY LAND BEHAVIORAL TEST TO ANALYZE ALZHEIMER’S DISEASE MOUSE MODELS FOR SPATIAL LEARNING DEFICITS
Roland Rabl, Stephan Kurat, Iera Hernandez, Estibaliz Santiago, Stefanie Flunkert, Birgit Hutter-Paier
FOCALLY INDUCED TAU PATHOLOGY IN APPSL MICE CLOSER MIMICS ALZHEIMER’S DISEASE SPATIO‐TEMPORAL PATHOLOG
Meritxell Aguiló1,2, Ewald Auer1, Tina Loeffler1, Balázs Dobrovich1, Joerg Neddens1, Stefanie Flunkert1, Robert Zimmermann2, Birgit Hutter‐Paier1
2University of Graz, Institute of Molecular Biosciences, Graz, Austria
SERUM VEGF LEVELS ARE ASSOCIATED WITH COGNITION AND FUNCTIONING IN AD: INFLUENCE OF THE TREATMENT WITH CEREBROLYSIN AND DONEPEZIL
A. Alvarez1,2, I. Alvarez1, O. Iglesias2, M. Aleixandre3, C. Linares4, J. Figueroa1,5
2Clinical Research Department, QPS Holdings, A Coruña, Spain.
3Faculty of Psychology, University of Granada, Granada, Spain.
4Faculty of Medicine, University of Malaga, Malaga, Spain.
5Santiago de Compostela University Hospital, Santiago de Compostela, Spain.
UNTANGLING ALZHEIMER’S DISEASE HALLMARKS IN SENSORY SYSTEMS OF RODENT MODELS
Roland Rabl, Meritxell Aguiló, Tina Löffler, Jörg Neddens, Ainara Lopez, Vera Niederkofler, Stefanie Flunkert and Birgit Hutter-Paier
7th International Dietary Fibre Conference 2018
Jun. 4th - 6th, 2018 | Rotterdam, NL
NUTRIOSE®, A SOLUBLE FIBRE WITH DEMONSTRATED BENEFITS FOR BLOOD GLUCOSE MANAGEMENT IN HUMANS
Guérin-Deremaux L1, Hobden MR2, Thabuis C1, Vazhappilly R1, Kalman D3, Kennedy OB2
2University of Reading, Department of Food and Nutritional Sciences, Reading, UK
3QPS Bio-Kinetic, Springfield, USA
66th ASMS Conference 2018
Jun. 3rd - 7th, 2018 | San Diego, CA
A FAST, ROBUST, AND GENERIC IA-LC-MS/MS METHOD FOR QUANTIFICATION OF MONOCLONAL ANTIBODY THERAPEUTICS: OPTIMIZING IMMUNOAFFINITY CAPTURE, PROTEOLYTIC DIGEST, AND LC CONDITIONS
Shuyu Hou, Feng-Ming James Chang, Kevin Pei, Mark Kai Leung Ho, Tyler Prusisz, Susan Zondlo, and John Kolman
WRIB – Workshop on Recent Issues in Bioanalysis 2018
Apr. 9th - 13th, 2018 | Philadelphia, PA
DEVELOPMENT OF A UPLC-MS/MS METHOD FOR THE DETERMINATION OF NORETHINDRONE FROM HUMAN PLASMA
Lan Li, Jinlan Dong, Tracey Paxson, Lin Zhang, Yuan-Shek Chen
AN LC-MS/MS METHOD FOR THE EVALUATION OF FF-10502-01 INCORPORATION INTO WHOLE BLOOD CELLULAR DNA AS A PHARMACODYNAMIC MARKER
Yuzhu Xue1, Tiffany Chen1, Brittney Offenbacker1, MingLai Cheng1, Takayuki Yamada2, Timothy Madden3, Yuan-Shek Chen1, Jamie Zhao1, Susan Carr Zondlo1
2FUJIFILM Corporation, Tokyo, Japan
3FUJIFILM Pharmaceuticals U.S.A., Inc., Cambridge, Massachusetts
DEVELOPMENT OF A UPLC-MS/MS METHOD FOR THE SIMULTANEOUS DETERMINATION OF FIVE MONOMETHYL AURISTATIN E (MMAE) METABOLITES FROM HUMAN PLASMA
Lan Li1, Tracey Paxson1, Yuan-Shek Chen1, Martin Paton2, Mark Qian2
2Millennium: The Takeda Oncology Company
DEVELOPMENT OF A UPLC-MS/MS METHOD FOR THE DETERMINATION OF MLN9708 AND ITS ENANTIOMER FROM HUMAN PLASMA
Lan Li1, Yuan-Shek Chen1, Martin Paton2, Mark Qian2
2Millennium: The Takeda Oncology Company
VALIDATION OF A POLYMERASE CHAIN REACTION (RT-qPCR) TO QUANTIFY A CODON-OPTIMIZED HUMAN CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MRNA (CO-hCFTR)
MingLai Cheng1, Katherine Domingue1, Lihong Gao2, Jonathan Abysalh2, Teresa White2, Susan Zondlo1, and John L. Kolman1
2Translate Bio, Cambridge, Massachusetts
ASCPT 2018
Mar. 21st - 24th, 2018 | Orlando, FL
A STUDY TO EVALUATE THE PHARMACOKINETICS AND TASTE PROFILE OF A PROTOTYPE ORALLY DISINTEGRATING TABLET FORMULATION FOR MK-0663
Peter Dogterom1, Khalid Abd Elaziz1, Ruben de Jong1, Susan J. Lee2 and Paul Fackler2
2Merck, Sharp & Dohme Corp, a subsidiary of Merck & Co., Inc, Kenilworth, NJ, USA